GI & Endoscopy

The FDA warned clinicians the SARS-CoV-2 virus, which causes COVID-19, may be transmitted in fecal samples during fecal microbiota transplants.

Takeda partnered with Evox Therapeutics in a deal worth $882 million to develop up to five rare disease programs, Pharmaphorum reports.

Motus GI gained CE Mark approval for its GEN2 Pure-Vu System, a colonoscopy device designed to facilitate the cleaning of a poorly prepared colon, according to a March 27 announcement.

Four COVID-19 updates for gastroenterologists this week:

Gastroenterologists treating COVID-19 patients have a number of resources to help guide them, including statements from professional societies and dedicated websites with information on the virus.

CMS recommends that all elective gastroenterology procedures be delayed during the COVID-19 pandemic to free up resources and limit exposure.

Here are four updates from gastroenterology companies and practices from the past week:

Patients with polyps had a higher risk of developing colorectal cancer than the general population, according to a study published in Lancet Gastroenterology & Hepatology.  

Five must read articles for gastroenterologists this week:

The American Gastroenterological Association released a collection of the latest studies around COVID-19 to provide up-to-date research to gastroenterologists.